Molecular Cancer Therapeutics

Published by: American Association for Cancer Research  

People

  1. Heller
    Heller
  2. Scher
    Scher
  3. Schwartz
    Schwartz
  4. Aras
    Aras
  5. Danila
    Danila
  6. Drilon
    Drilon
  7. Fagin
    Fagin
  8. Fleisher
    Fleisher
  9. Ganly
    Ganly
  10. Ghossein
    Ghossein

Groups

  1. Body Imaging Service (5)
  2. Department of Medicine (5)
  3. Radiology, Department of (5)
  4. Solid Tumor Oncology Division (4)
  5. Epidemiology and Biostatistics (3)
  6. GSK Faculty (3)
  7. Biostatistics Service (2)
  8. Department of Pathology and Laboratory Medicine (2)
  9. Genitourinary Oncology Service (2)
  10. Hematologic Malignancies, Division of (2)
Search Within
  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Body Imaging Service (5)
  2. Department of Medicine (5)
  3. Radiology, Department of (5)
  4. Solid Tumor Oncology Division (4)
  5. Epidemiology and Biostatistics (3)
  6. GSK Faculty (3)

More Groups

People
  1. Glenn Heller (2)
  2. Howard Scher (2)
  3. Lawrence Schwartz (2)
  4. Alexander Drilon (1)
  5. Alison Schram (1)
  6. Ariela Noy (1)

More People

Years
  1. 2022 (1)
  2. 2019 (1)
  3. 2007 (3)
Publishers
  1. American Association for Cancer Research (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Dulude, H.; Pancha, C.; Czanny, M.; Curley, T.; Morris, M.; Rathkopf, D.; Schwartz, L.; Heller, G.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save

    • Molecular Cancer Therapeutics – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular cancer therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 Unknown
    Molecular Cancer Therapeutics 15357163 The Authors the American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 Unknown
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research